Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH CML 2022 | Gene knockdown strategies to investigate the properties of leukemic stem cells

Andrew Wu • 22 Oct 2022
ESH CML 2022
Chronic Myeloid Leukemia Leukemia

Andrew Wu, BS, MS, British Columbia Cancer Agency, Vancouver, Canada, outlines different gene knockdown methods that can be used to investigate the properties of leukemic stem cells (LSCs), including short hairpin RNA (shRNA)-mediated gene silencing, CRISPR/Cas9-mediated knockdown, and using lipid nanoparticles for small interfering (siRNA) delivery. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Andrew Wu

1:49
The use of miRNAs as predictive biomarkers in CML
Andrew Wu • 22 Oct 2022
1:06
The potential of targeting PAK6 in CML
Andrew Wu • 22 Oct 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals